Celcuity

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.

CEO

Brian F. Sullivan

CEOBrian F. Sullivan

Employees

Employees39

Headquarters

Minneapolis, Minnesota

HeadquartersMinneapolis, Minnesota

Founded

2012

Founded2012

Employees

Employees39

CELC Key Statistics

Market cap

151.95M

Market cap151.95M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

52.08K

Average volume52.08K

High today

$10.22

High today$10.22

Low today

$9.43

Low today$9.43

Open price

$9.43

Open price$9.43

Volume

37.78K

Volume37.78K

52 Week high

$19.93

52 Week high$19.93

52 Week low

$4.81

52 Week low$4.81

CELC Earnings

-$0.66

-$0.44

-$0.22

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 7, After Hours

ActualExpected Nov 7, After Hours

Celcuity

Why Robinhood?

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Show more

CELC Key Statistics

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.